Cargando…
Targeting PPARγ Signaling Cascade for the Prevention and Treatment of Prostate Cancer
The peroxisome proliferator-activated receptor-gamma (PPARγ) is a member of the hormone-activated nuclear receptor superfamily. PPARγ can be activated by a diverse group of agents, such as endogenous polyunsaturated fatty acids, 15-deoxy-Δ(12,14)-prostaglandin J(2) (15d-PGJ(2)), and thiazolidinedion...
Autores principales: | Sikka, Sakshi, Chen, Luxi, Sethi, Gautam, Kumar, Alan Prem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3504464/ https://www.ncbi.nlm.nih.gov/pubmed/23213321 http://dx.doi.org/10.1155/2012/968040 |
Ejemplares similares
-
Corilagin Represses Epithelial to Mesenchymal Transition Process Through Modulating Wnt/β-Catenin Signaling Cascade
por: Hwang, Sun Tae, et al.
Publicado: (2020) -
Epigenetic derepression converts PPARγ into a druggable target in triple-negative and endocrine-resistant breast cancers
por: Loo, Ser Yue, et al.
Publicado: (2021) -
Possible role of PPARγ in the negative regulation of ovulatory cascade and
luteal development in rats
por: FUNAHASHI, Ryohei, et al.
Publicado: (2017) -
The role of PPARγ in prostate cancer development and progression
por: Hartley, Andrew, et al.
Publicado: (2022) -
Revisiting PPARγ as a target for the treatment of metabolic disorders
por: Choi, Sun-Sil, et al.
Publicado: (2014)